The study authors suggest that AI, particularly when pre-trained through methodical prompts, can serve as a viable tool to ...

Stomach cancers are increasingly being diagnosed at less advanced, more treatable stages - a shift that marks major progress ...

Background Children and young people with severe neurodisabling conditions (CYPSND)experience severe functional ...

The Artificial Urinary Sphincter Clinical Outcomes Trial (AUSCO) represented the first attempt at rigorous application of the ...

Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with ...

Drug approval is unequivocally the linchpin to any drug development effort and, given the role of the US market in the global ...

Myriad Genetics' growth potential lies in its innovative products, strong financials, and expanding market opportunities.

Experts are reaching consensus about screening and surveillance for high-risk patients, similar to guidelines for the colon ...

Nearly half of the N.I.H. grants canceled through early May — together worth more than $800 million — addressed the health of ...

Kardium today announced one-year clinical trial results for its Globe PF pulsed field ablation (PFA) system for treating AFib ...

There were 26.4 deaths per 100,000 people from diabetes, according to early death certificate data for the third quarter of ...